How Laser Therapy Device Can Provide Lasting Joint Pain Relief
Light therapy at the correct wavelength and dosage (like the Move+ provides) can help stop or reduce pain, and can with consistent use, stimulate the healing process within the joint.
Targeted red light therapy is great for honing in on specific areas of the body for treatment
We combine LEDs with medical-grade laser technology, for more effective and impactful dosing of internal tissue
MOVE+ is a safe, non-invasive, enhanced light therapy device specially engineered to relieve joint pain and support the recovery process.
There are a lot of red light therapy devices on the market today, from full-panel devices to those that focus on the specific area. If you’re one of the many people suffering from arthritis, you might be desperate for anything that can bring relief. You’ve probably tried medication, physical therapy, and maybe even acupuncture. But there’s a new treatment out there that may be worth trying: red light therapy. Red light therapy provides pain relief by speeding up the body’s natural healing processes at the cellular level. The soothing light helps to reduce swelling and inflammation, while also increasing blood circulation and providing pain relief directly to the area being stimulated.
Panels Don’t Work For Internal Tissue
One of the main factors that differs Kineon from others is the optimal dosing provided with each use. The Move+ is the only home-use laser device for pain relief and healing on the market. Unlike panel lights the Move+ technology ensures that the device delivers the right dosage at the right time because it sits against the skin and has been designed based on a proprietary dosing model ensuring that patients are getting the best possible results from the treatments.
The Move+ works by using LED and Low Level Laser Light (photobiomodulation) to increase blood flow around damaged joint tissue and muscle. The increased blood flow allows for more nutrients and oxygen to be delivered as well as white blood cells to repair the damaged areas. LED light helps restore the skin and the low-level laser therapy light penetrates deep into the centre of the joint for powerful, soothing relief from joint pain and inflammation.
This device is especially beneficial for people suffering from chronic pain such as osteoarthritis and/or cartilage degradation, as well as professional athletes, physical laborers, and the military.
Currently, the team of experts at Kineon is recommending 5 - 15 minutes per day for optimal results, depending on the issue being treated. Consistency is key, hence doing a short treatment every day will be more effective than doing longer sessions more sporadically.
Stop Taking Pain Killers Today AND Treat the Underlying Issue
In comparison to other treatments they've tried, the thousands of current Move+ users claim an 80% reduction in pain between one to four weeks of using the gadget. Along with the US Army, athletes from the NBA, UFC, NFL, and Olympics use it.
“I’ve seen tremendous results,” says Mario Butler, former NFL Cornerback and Move+ user. “I’m now back to 100%.”
The Move+ is supported by science, so it's not just customers who are singing praises. More than 6,000 clinical investigations conducted over the past few years have shown the beneficial effects of red light treatment, and the Kineon Move+ is the most effective device now available.
For more information, please visit https://kineon.io/
Established in 2021, Kineon Labs (formerly Reviiv Light) is bringing the latest advancements in enhanced red light therapy for home use. Their mission is to improve the quality of life of the largest number of people in the most substantial way possible. Kineon’s flagship product, MOVE+ is a safe, non-invasive, enhanced light therapy device specially engineered to relieve joint pain and support the recovery process.
VIDEO URL: https://www.youtube.com/watch?v=hilaUAqYu-Q
Analyn Maer
Kineon Labs
+63 976 309 1855
email us here
Visit us on social media:
Facebook
LinkedIn
Other
Science Explanation on the Kineon Move +
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
